glp-1 release Mechanism of action of agonists – My Endo Consult GLP-1 Medications – Community Education

KAM research found that an astounding 7% of UK adults are currently using GLP-1 drugs for weight loss

AS GLP-1s ORIGINALLY INTENDED TO TREAT TYPE 2 DIABETES (T2D) AND OFTEN DELIVERED WITH INJECTION PENS DEVELOPED FOR INSULIN ARE INCREASINGLY USED TO TREAT OBESITY, PERHAPS IT IS WORTH RETHINKING THE BASIS OF THESE DESIGNS TO ACCOMMODATE A USER GROUP THAT MAY HAVE DIFFERENT REQUIREMENTS. People with diabetes depend on these devices for survival, and the devices have been optimised accordingly for their ease of use, safety and reliability

Some users experience mild gas, bloating, or changes in their stool during the first week as their gut adapts to the new bacteria

Because of this, patients taking it primarily for weight loss often worry about their blood sugar dropping dangerously low (hypoglycemia)